Companies Layoffs Report Technical Review 
socalTECH
JULY 17, 2012
You may not see it here in Southern California's high tech sector--which has been booming, due to a surge of startup and accelerator activity--but apparently, the technology sector has seen its highest level of layoffs in three years, according to a report today. Image courtesy Bigstock.com READ MORE>>.
Tech.Co
JUNE 24, 2022
A number of tech companies have made the headlines this week for hiring new members of staff, only to rescind such offers before they start. Get all the latest tech news straight to your inbox. The Wall Street Journal reports that Twitter, for instance, has refused to take on new staff it previously offered jobs to.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Tech Zulu Event
AUGUST 14, 2012
A company it bought in May. The company will also close a third of its offices worldwide. Motorola annual financial report is here. Google will however feel the layoffs. The post Google Confirms Motorola Mobility 4000 Layoffs appeared first on TechZulu.
Xconomy
OCTOBER 7, 2016
military’s high-tech think tank DARPA described Safe Genes, a new program to fund safety measures that can be built into genome editing technology or counter its potential wayward effects. —The 2016 Nobel Prize for Physiology or Medicine went to Yoshinori Ohsumi of the Tokyo Institute of Technology. —The U.S.
Xconomy
JULY 1, 2016
There was plenty more biomedical news this week, from a downsized IPO to downsizing companies, while ugly sexual harassment details emerged in Seattle. To boost the initiative, which aims to speed the pace of cancer research, FDA said it would consolidate its cancer review divisions under the Oncology Center of Excellence.
Xconomy
JULY 15, 2016
There were other goodbyes: Peter DiLaura said so long to Second Genome, the microbiome company he led for six years. —The federal group that runs Medicare and Medicaid banned Theranos CEO Elizabeth Holmes from running a lab for two years, throwing into question the viability of the company. —Enough good trial news.
Xconomy
JUNE 17, 2016
The filing held some surprises , however, as Xconomy reported: plans to convert about $200 million in debt—a massive amount for a privately held biotech—into shares at the IPO, with some of those shares holding special privileges for their owners. —Ben Fidler contributed to this report. Reprints | Share:
Expert insights. Personalized for you.
133 
Let's personalize your content